193 related articles for article (PubMed ID: 32049107)
21. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder.
Hung KF; Liu CJ; Chiu PC; Lin JS; Chang KW; Shih WY; Kao SY; Tu HF
Oral Oncol; 2016 Feb; 53():42-7. PubMed ID: 26675284
[TBL] [Abstract][Full Text] [Related]
22. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
23. [Precancerous lesions of the mouth].
Seirul-Lo Vargas FJ; Salas Llama C
Rev Esp Estomatol; 1981; 29(5):297-306. PubMed ID: 6950472
[No Abstract] [Full Text] [Related]
24. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
26. Exfoliative cytology as a tool for monitoring pre-malignant and malignant lesions based on combined stains and morphometry techniques.
Gonzalez Segura I; Secchi D; Carrica A; Barello R; Arbelo D; Burgos A; Brunotto M; Zarate AM
J Oral Pathol Med; 2015 Mar; 44(3):178-84. PubMed ID: 25065639
[TBL] [Abstract][Full Text] [Related]
27. Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype.
Iocca O; Sollecito TP; Alawi F; Weinstein GS; Newman JG; De Virgilio A; Di Maio P; Spriano G; Pardiñas López S; Shanti RM
Head Neck; 2020 Mar; 42(3):539-555. PubMed ID: 31803979
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
Gupta K; Metgud R; Gupta J
J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
[TBL] [Abstract][Full Text] [Related]
29. Expression of Salivary miRNA 21 in Oral Submucous Fibrosis (OSMF): An Observational Study.
Prasad SR; Pai A; Shyamala K; Yaji A
Microrna; 2020; 9(4):295-302. PubMed ID: 31985389
[TBL] [Abstract][Full Text] [Related]
30. Isolation and Quantification of MicroRNAs from Human Saliva.
Arunachalam SR; Tang KD; Punyadeera C
Methods Mol Biol; 2019; 2054():105-114. PubMed ID: 31482450
[TBL] [Abstract][Full Text] [Related]
31. Salivary LDH in oral cancer and potentially malignant disorders: A systematic review and meta-analysis.
Iglesias-Velázquez Ó; López-Pintor RM; González-Serrano J; Casañas E; Torres J; Hernández G
Oral Dis; 2022 Jan; 28(1):44-56. PubMed ID: 32881152
[TBL] [Abstract][Full Text] [Related]
32. Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?
Coletta RD; Salo T
Oral Dis; 2018 Mar; 24(1-2):84-88. PubMed ID: 29480603
[TBL] [Abstract][Full Text] [Related]
33. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
34. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses.
Awan KH; Morgan PR; Warnakulasuriya S
J Oral Pathol Med; 2011 Aug; 40(7):541-4. PubMed ID: 21615500
[TBL] [Abstract][Full Text] [Related]
35. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.
Müller S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637
[TBL] [Abstract][Full Text] [Related]
36. Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: A systematic review.
Maheswari TNU; Venugopal A; Sureshbabu NM; Ramani P
Ci Ji Yi Xue Za Zhi; 2018; 30(2):55-60. PubMed ID: 29875583
[TBL] [Abstract][Full Text] [Related]
37. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
38. Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan.
Tsai KY; Su CC; Chiang CT; Tseng YT; Lian IB
Cancer Epidemiol; 2017 Apr; 47():118-124. PubMed ID: 28259083
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
40. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
